Zeitschriftenartikel zum Thema „Leukemia inhibitory factor“
Geben Sie eine Quelle nach APA, MLA, Chicago, Harvard und anderen Zitierweisen an
Machen Sie sich mit Top-50 Zeitschriftenartikel für die Forschung zum Thema "Leukemia inhibitory factor" bekannt.
Neben jedem Werk im Literaturverzeichnis ist die Option "Zur Bibliographie hinzufügen" verfügbar. Nutzen Sie sie, wird Ihre bibliographische Angabe des gewählten Werkes nach der nötigen Zitierweise (APA, MLA, Harvard, Chicago, Vancouver usw.) automatisch gestaltet.
Sie können auch den vollen Text der wissenschaftlichen Publikation im PDF-Format herunterladen und eine Online-Annotation der Arbeit lesen, wenn die relevanten Parameter in den Metadaten verfügbar sind.
Sehen Sie die Zeitschriftenartikel für verschiedene Spezialgebieten durch und erstellen Sie Ihre Bibliographie auf korrekte Weise.
Nicola, Nicos A., und Jeffrey J. Babon. „Leukemia inhibitory factor (LIF)“. Cytokine & Growth Factor Reviews 26, Nr. 5 (Oktober 2015): 533–44. http://dx.doi.org/10.1016/j.cytogfr.2015.07.001.
Metcalf, Donald. „The leukemia inhibitory factor (LIF)“. International Journal of Cell Cloning 9, Nr. 2 (1991): 95–108. http://dx.doi.org/10.1002/stem.5530090201.
Vanchieri, C. „Leukemia Inhibitory Factor Has Multiple Personalities“. JNCI Journal of the National Cancer Institute 86, Nr. 4 (16.02.1994): 262. http://dx.doi.org/10.1093/jnci/86.4.262.
Hinds, Mark G., Till Maurer, Jian-Guo Zhang, Nicos A. Nicola und Raymond S. Norton. „Solution Structure of Leukemia Inhibitory Factor“. Journal of Biological Chemistry 273, Nr. 22 (29.05.1998): 13738–45. http://dx.doi.org/10.1074/jbc.273.22.13738.
Senturk, Levent M., und Aydin Arici. „Leukemia Inhibitory Factor in Human Reproduction“. American Journal of Reproductive Immunology 39, Nr. 2 (Februar 1998): 144–51. http://dx.doi.org/10.1111/j.1600-0897.1998.tb00346.x.
RAY, DAVID W., SONG-GUANG REN und SHLOMO MELMED. „Leukemia Inhibitory Factor Regulates Proopiomelanocortin Transcriptiona“. Annals of the New York Academy of Sciences 840, Nr. 1 (Mai 1998): 162–73. http://dx.doi.org/10.1111/j.1749-6632.1998.tb09560.x.
Lass, Amir, Weishui Weiser, Alain Munafo und Ernest Loumaye. „Leukemia inhibitory factor in human reproduction“. Fertility and Sterility 76, Nr. 6 (Dezember 2001): 1091–96. http://dx.doi.org/10.1016/s0015-0282(01)02878-3.
Hilton, Douglas J., und Nicholas M. Gough. „Leukemia inhibitory factor: A biological perspective“. Journal of Cellular Biochemistry 46, Nr. 1 (Mai 1991): 21–26. http://dx.doi.org/10.1002/jcb.240460105.
Pepper, M. S., N. Ferrara, L. Orci und R. Montesano. „Leukemia inhibitory factor (LIF) inhibits angiogenesis in vitro“. Journal of Cell Science 108, Nr. 1 (01.01.1995): 73–83. http://dx.doi.org/10.1242/jcs.108.1.73.
Hanington, Patrick C., Shunmoogum A. Patten, Laura M. Reaume, Andrew J. Waskiewicz, Miodrag Belosevic und Declan W. Ali. „Analysis of leukemia inhibitory factor and leukemia inhibitory factor receptor in embryonic and adult zebrafish (Danio rerio)“. Developmental Biology 314, Nr. 2 (Februar 2008): 250–60. http://dx.doi.org/10.1016/j.ydbio.2007.10.012.
Pehlivan, Melek, Ceyda Caliskan, Zeynep Yuce und Hakkı Ogun Sercan. „Forced expression of Wnt antagonists sFRP1 and WIF1 sensitizes chronic myeloid leukemia cells to tyrosine kinase inhibitors“. Tumor Biology 39, Nr. 5 (Mai 2017): 101042831770165. http://dx.doi.org/10.1177/1010428317701654.
Vernallis, Ann B., Keith R. Hudson und John K. Heath. „An Antagonist for the Leukemia Inhibitory Factor Receptor Inhibits Leukemia Inhibitory Factor, Cardiotrophin-1, Ciliary Neurotrophic Factor, and Oncostatin M“. Journal of Biological Chemistry 272, Nr. 43 (24.10.1997): 26947–52. http://dx.doi.org/10.1074/jbc.272.43.26947.
Metcalf, D. „The Unsolved Enigmas of Leukemia Inhibitory Factor“. Stem Cells 21, Nr. 1 (01.01.2003): 5–14. http://dx.doi.org/10.1634/stemcells.21-1-5.
Gulluoglu, Sukru, Mesut Sahin, Emre Can Tuysuz, Cumhur Kaan Yaltirik, Aysegul Kuskucu, Ferda Ozkan, Fikrettin Sahin, Ugur Ture und Omer Faruk Bayrak. „Leukemia Inhibitory Factor Promotes Aggressiveness of Chordoma“. Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics 25, Nr. 7 (07.08.2017): 1177–88. http://dx.doi.org/10.3727/096504017x14874349473815.
AGHAJANOVA, LUSINE. „Leukemia Inhibitory Factor and Human Embryo Implantation“. Annals of the New York Academy of Sciences 1034, Nr. 1 (Dezember 2004): 176–83. http://dx.doi.org/10.1196/annals.1335.020.
Metcalf, Donald. „Leukemia Inhibitory Factor—A Puzzling Polyfunctional Regulator“. Growth Factors 7, Nr. 3 (Januar 1992): 169–73. http://dx.doi.org/10.3109/08977199209046921.
GEARING, DAVID P. „Leukemia Inhibitory Factor: Does the Cap Fit?“ Annals of the New York Academy of Sciences 628, Nr. 1 Negative Regu (Juli 1991): 9–18. http://dx.doi.org/10.1111/j.1749-6632.1991.tb17218.x.
KURZROCK, RAZELLE, ZEEV ESTROV, MEIR WETZLER, JORDAN U. GUTTERMAN und OSHE MTALPAZ. „LIF: Not Just a Leukemia Inhibitory Factor*“. Endocrine Reviews 12, Nr. 3 (August 1991): 208–17. http://dx.doi.org/10.1210/edrv-12-3-208.
Cornish, J., K. E. Callon, S. G. Edgar und I. R. Reid. „Leukemia inhibitory factor is mitogenic to osteoblasts“. Bone 21, Nr. 3 (September 1997): 243–47. http://dx.doi.org/10.1016/s8756-3282(97)00144-0.
Tran, Ami, Kalman Kovacs, Lucia Stefaneanu, George Kontogeorgos, Bernd W. Scheithauer und Shlomo Melmed. „Expression of leukemia inhibitory factor in craniopharyngioma“. Endocrine Pathology 10, Nr. 2 (Juni 1999): 103–8. http://dx.doi.org/10.1007/bf02739822.
Waring, Paul M., Roberto Romero, Nihay Laham, Ricardo Gomez und Gregory E. Rice. „Leukemia inhibitory factor: Association with intraamniotic infection“. American Journal of Obstetrics and Gynecology 171, Nr. 5 (November 1994): 1335–41. http://dx.doi.org/10.1016/0002-9378(94)90157-0.
Weber, Marietta A., Silvia Schnyder-Candrian, Bruno Schnyder, Valerie Quesniaux, Valeria Poli, Colin L. Stewart und Bernhard Ryffel. „Endogenous leukemia inhibitory factor attenuates endotoxin response“. Laboratory Investigation 85, Nr. 2 (20.12.2004): 276–84. http://dx.doi.org/10.1038/labinvest.3700216.
Lemons, Angela R., und Rajesh K. Naz. „Birth control vaccine targeting leukemia inhibitory factor“. Molecular Reproduction and Development 79, Nr. 2 (02.12.2011): 97–106. http://dx.doi.org/10.1002/mrd.22002.
Hanson, J. M., J. A. Mol und B. P. Meij. „Expression of leukemia inhibitory factor and leukemia inhibitory factor receptor in the canine pituitary gland and corticotrope adenomas“. Domestic Animal Endocrinology 38, Nr. 4 (Mai 2010): 260–71. http://dx.doi.org/10.1016/j.domaniend.2009.11.005.
Na, Bon Hyang, Thi Xoan Hoang und Jae Young Kim. „Hsp90 Inhibition Reduces TLR5 Surface Expression and NF-κB Activation in Human Myeloid Leukemia THP-1 Cells“. BioMed Research International 2018 (2018): 1–8. http://dx.doi.org/10.1155/2018/4319369.
Auernhammer, C. J., und S. Melmed. „Leukemia-Inhibitory Factor—Neuroimmune Modulator of Endocrine Function*“. Endocrine Reviews 21, Nr. 3 (01.06.2000): 313–45. http://dx.doi.org/10.1210/edrv.21.3.0400.
Okabe, M., Y. Kuni-eda, T. Sugiwura, M. Tanaka, T. Miyagishima, I. Saiki, T. Minagawa, M. Kurosawa, T. Itaya und T. Miyazaki. „Inhibitory effect of interleukin-4 on the in vitro growth of Ph1- positive acute lymphoblastic leukemia cells“. Blood 78, Nr. 6 (15.09.1991): 1574–80. http://dx.doi.org/10.1182/blood.v78.6.1574.1574.
Okabe, M., Y. Kuni-eda, T. Sugiwura, M. Tanaka, T. Miyagishima, I. Saiki, T. Minagawa, M. Kurosawa, T. Itaya und T. Miyazaki. „Inhibitory effect of interleukin-4 on the in vitro growth of Ph1- positive acute lymphoblastic leukemia cells“. Blood 78, Nr. 6 (15.09.1991): 1574–80. http://dx.doi.org/10.1182/blood.v78.6.1574.bloodjournal7861574.
LI, Yong, Lizhou SUN, Denmei ZHAO, Jun OUYANG und Mei XIANG. „Aberrant expression of leukemia inhibitory factor receptor (LIFR) and leukemia inhibitory factor (LIF) is associated with tubal pregnancy occurrence“. TURKISH JOURNAL OF MEDICAL SCIENCES 45 (2015): 214–20. http://dx.doi.org/10.3906/sag-1307-103.
Wysoczynski, Marcin, Katarzyna Miekus, Kacper Jankowski, Jens Wanzeck, Salvatore Bertolone, Anna Janowska-Wieczorek, Janina Ratajczak und Mariusz Z. Ratajczak. „Leukemia Inhibitory Factor: A Newly Identified Metastatic Factor in Rhabdomyosarcomas“. Cancer Research 67, Nr. 5 (01.03.2007): 2131–40. http://dx.doi.org/10.1158/0008-5472.can-06-1021.
Reinart, Nina, Malgorzata Ciesla, Cornelia Rudolph, Astrid Stein, Guenter Krause, Brigitte Schlegelberger, Michael Hallek und Guenter Fingerle-Rowson. „Macrophage Migration Inhibitory Factor (MIF) Promotes the Development of Murine Chronic Lymphocytic Leukemia (CLL)“. Blood 112, Nr. 11 (16.11.2008): 27. http://dx.doi.org/10.1182/blood.v112.11.27.27.
Uno, Kanako, Takeshi Inukai, Nobuhiko Kayagaki, Kumiko Goi, Hiroki Sato, Atsushi Nemoto, Kazuya Takahashi et al. „TNF-related apoptosis-inducing ligand (TRAIL) frequently induces apoptosis in Philadelphia chromosome–positive leukemia cells“. Blood 101, Nr. 9 (01.05.2003): 3658–67. http://dx.doi.org/10.1182/blood-2002-06-1770.
Yokoyama, A., J. Okabe-Kado, A. Sakashita, N. Maseki, Y. Kaneko, K. Hino, S. Tomoyasu, N. Tsuruoka, T. Kasukabe und Y. Honma. „Differentiation inhibitory factor nm23 as a new prognostic factor in acute monocytic leukemia“. Blood 88, Nr. 9 (01.11.1996): 3555–61. http://dx.doi.org/10.1182/blood.v88.9.3555.bloodjournal8893555.
Conover, J. C., N. Y. Ip, W. T. Poueymirou, B. Bates, M. P. Goldfarb, T. M. DeChiara und G. D. Yancopoulos. „Ciliary neurotrophic factor maintains the pluripotentiality of embryonic stem cells“. Development 119, Nr. 3 (01.11.1993): 559–65. http://dx.doi.org/10.1242/dev.119.3.559.
Park, Hye-Rin, Hee-Jung Choi, Bo-Sung Kim, Tae-Wook Chung, Keuk-Jun Kim, Jong-Kil Joo, Dongryeol Ryu, Sung-Jin Bae und Ki-Tae Ha. „Paeoniflorin Enhances Endometrial Receptivity through Leukemia Inhibitory Factor“. Biomolecules 11, Nr. 3 (16.03.2021): 439. http://dx.doi.org/10.3390/biom11030439.
Estrov, Zeev, Moshe Talpaz, Meir Wetzler und Razelle Kurzrock. „The Modulatory Hematopoietic Activities of Leukemia Inhibitory Factor“. Leukemia & Lymphoma 8, Nr. 1-2 (Januar 1992): 1–7. http://dx.doi.org/10.3109/10428199209049811.
REID, I. R., C. LOWE, J. CORNISH, S. J. M. SKINNER, D. J. HILTON, T. A. WILLSON, D. P. GEARING und T. J. MARTIN. „Leukemia Inhibitory Factor: A Novel Bone-Active Cytokine*“. Endocrinology 126, Nr. 3 (März 1990): 1416–20. http://dx.doi.org/10.1210/endo-126-3-1416.
Knight, D., und T. Bai. „Roles for leukemia inhibitory factor in lung biology“. Drug News & Perspectives 12, Nr. 5 (1999): 261. http://dx.doi.org/10.1358/dnp.1999.12.5.863620.
Auernhammer, C. J. „Leukemia-Inhibitory Factor--Neuroimmune Modulator of Endocrine Function“. Endocrine Reviews 21, Nr. 3 (01.06.2000): 313–45. http://dx.doi.org/10.1210/er.21.3.313.
van den Bent, Martin J. „Prevention of Chemotherapy-Induced Neuropathy: Leukemia Inhibitory Factor“. Clinical Cancer Research 11, Nr. 5 (01.03.2005): 1691–93. http://dx.doi.org/10.1158/1078-0432.ccr-05-0079.
Ishizaki, Seiji, Takashi Murase, Yoshihisa Sugimura, Ryoichi Banno, Hiroshi Arima, Yoshitaka Miura und Yutaka Oiso. „Leukemia inhibitory factor stimulates vasopressin release in rats“. Neuroscience Letters 359, Nr. 1-2 (April 2004): 77–80. http://dx.doi.org/10.1016/j.neulet.2004.02.019.
McCoy, A. J., V. Staton, A. Van Donkelaar, J. N. Varghese und P. M. Colman. „X-ray crystallographic studies of leukemia inhibitory factor“. Acta Crystallographica Section A Foundations of Crystallography 49, s1 (21.08.1993): c113. http://dx.doi.org/10.1107/s0108767378096750.
Gearing, David P. „Molecular characterization of the leukemia inhibitory factor receptor“. Fresenius' Journal of Analytical Chemistry 343, Nr. 1 (1992): 14–15. http://dx.doi.org/10.1007/bf00331947.
Cornish, J., C. Lowe, S. J. M. Skinner, D. J. Hilton, T. A. Willson, D. P. Gearing, T. J. Martin und I. R. Reid. „Leukemia inhibitory factor: A novel bone-active cytokine“. Bone and Mineral 10, Nr. 3 (September 1990): S290. http://dx.doi.org/10.1016/0169-6009(90)90322-7.
Liu, Shu-Chen, und Yu-Sun Chang. „Role of leukemia inhibitory factor in nasopharyngeal carcinogenesis“. Molecular & Cellular Oncology 1, Nr. 1 (Januar 2014): e29900. http://dx.doi.org/10.4161/mco.29900.
Villiger, P. M., Y. Geng und M. Lotz. „Induction of cytokine expression by leukemia inhibitory factor.“ Journal of Clinical Investigation 91, Nr. 4 (01.04.1993): 1575–81. http://dx.doi.org/10.1172/jci116363.
Marshall, Jean S., Jack Gauldie, Laurie Nielsen und John Bienenstock. „Leukemia inhibitory factor production by rat mast cells“. European Journal of Immunology 23, Nr. 9 (September 1993): 2116–20. http://dx.doi.org/10.1002/eji.1830230911.
Lowe, Carolyn, Jill Cornish, Karon Callon, John T. Martin und Ian R. Reid. „Regulation of osteoblast proliferation by leukemia inhibitory factor“. Journal of Bone and Mineral Research 6, Nr. 12 (03.12.2009): 1277–83. http://dx.doi.org/10.1002/jbmr.5650061203.
Yue, Zhan-Peng, Zeng-Ming Yang, Peng Wei, Shi-Jie Li, Hong-Bin Wang, Jing-He Tan und Michael J. K. Harper. „Leukemia Inhibitory Factor, Leukemia Inhibitory Factor Receptor, and Glycoprotein 130 in Rhesus Monkey Uterus During Menstrual Cycle and Early Pregnancy1“. Biology of Reproduction 63, Nr. 2 (01.08.2000): 508–12. http://dx.doi.org/10.1095/biolreprod63.2.508.
Patterson, B., A. Tjernlund und J. Andersson. „Endogenous Inhibitors of HIV: Potent Anti-HIV Activity of Leukemia Inhibitory Factor“. Current Molecular Medicine 2, Nr. 8 (01.12.2002): 713–22. http://dx.doi.org/10.2174/1566524023361817.